References
- Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C. (2007). Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–8.
- Brockmann JG, St Nottberg H, Glodny B, Heinecke A, Senninger NJ. (2000). CYFRA 21-1 serum analysis in patients with esophageal cancer. Clin Cancer Res 6:4249–52.
- Gold P, Freedman SO. (1965a). Demonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques. J Exp Med 121:439–62.
- Gold P, Freedman SO. (1965b). Specific carcinoembryonic antigen of the human digestive system. J Exp Med 122:467–81.
- Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. (2003). Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–33.
- Kawaguchi H, Ohno S, Miyazaki M, Hashimoto K, Egashira A, Saeki H, Watanabe M, Sugimachi K. (2000). CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 89:1413–17.
- Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K. (2004). Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 28:680–5.
- Kunisaki C, Imada T, Yamada R, Hatori S, Kinbara K, Watai K, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Shimada H. (2006). Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma. Hepatogastroenterology 53:366–71.
- Mao YS, Zhang DC, Zhao XH, Wang LJ, Qi J, Li XX. (2003). Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer. Zhonghua Zhong Liu Za Zhi 25:457–60.
- Mroczko B, Kozłowski M, Groblewska M, łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L, Szmitkowski M. (2008). The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clin Chim Acta 389:61–6.
- Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K, Watanabe S. (1998). CYFRA21-1 as a tumor marker for squamous cell carcinoma of the esophagus. Dis Esophagus 11:35–9.
- Nakamura T, Matsunami K, Hayashi K, Ota M, Ide H, Takasaki K. (2004). Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol Rep 11:999–1003.
- Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y. (2003). Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer 97:3114–20.
- Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. (1999). Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915–21.
- Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. (1993). Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53:61–6.
- Stieber P, Hasholzner U, Bodenmüller H, Nagel D, Sunder-Plassmann L, Dienemann H, Meier W, Fateh-Moghadam A. (1993). CYFRA 21-1. A new marker in lung cancer. Cancer 72:707–13.
- Su M, Lu SM, Tian DP, Zhao H, Li XY, Li DR, Zheng ZC. (2001). Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol 7:657–61.
- van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA. (1994). Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra21-1. Br J Cancer 69:525–8.
- Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T. (2007). Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. J Gastroenterol Hepatol 22:715–19.
- Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T. (1997). CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 79:1647–55.